oseltamivir has been researched along with hydroxychloroquine in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (3.13) | 24.3611 |
| 2020's | 31 (96.88) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Duan, Y; Zhou, C; Zhu, HL | 1 |
| Kutlu, Ö; Metin, A | 1 |
| Rezaei, N; Yousefzadegan, S | 1 |
| Cutrell, JB; Jodlowski, TZ; Monogue, ML; Sanders, JM | 1 |
| Bekci, T | 1 |
| Ledford, H | 1 |
| Aydın, GÇ; Azap, A; Dursun, B; Öztürk, HH; Ürün, Y; Utkan, G; Yazgan, SC; Yekedüz, E | 1 |
| Berk, A; Duman, H; Kaya, F; Mutlu, H; Ozaras, R; Ucar, DH | 1 |
| Çapar, G; Köse, M; Medetalibeyoğlu, A; Şenkal, N; Tükek, T | 1 |
| Azadi, H; Darabi, E; Fathi, S; Ghanei, M; Ghazale, AH; Ghazvini, A; Izadi, M; Jafari, R; Movaseghi, F; Mozafari, A; Panahi, Y; Parsaei, MR; Ranjkesh, MH; Rezapour, M; Saadat, SH; Salesi, M; Vahedi, E; Zand, N | 1 |
| Amenta, F; Nittari, G; Pallotta, G; Tayebati, SK | 1 |
| Firouzabadi, FD; Firouzabadi, MD; Ghalehbaghi, B; Goudarzi, S; Jahandideh, H; Roomiani, M | 1 |
| Altunok, ES; Cengel, F; Ekin, EE; Gurkan, O; Yilmaz, A | 1 |
| Akram, J; Azhar, S; Khan, KS; Latif, W; Shahzad, M | 1 |
| Abd El Ghafar, MS; Abd-Elsalam, S; Abdo, EF; Ahmed, OA; Alboraie, M; Esmail, ES; Khalaf, M; Medhat, MA; Serangawy, GN; Soliman, S | 1 |
| Grundmark, B; Vidlin, SH; Watson, S; Zekarias, A | 1 |
| Mamishi, S; Navaeian, A; Shabanian, R | 1 |
| Aytekin, S; Aytekin, V; Çelik, HG; Ergönül, Ö; Kapmaz, M; Keske, Ş; Özyıldırım, A; Şahin, ŞT; Şener, Ü; Tekbaş, M | 1 |
| Akat, H; Laloglu, F; Orbak, Z | 1 |
| Bakheet, N; El-Shazly, M; Fouad, R; Hussin, W; Kassem, AM | 1 |
| Gao, Q; Liu, D; Ma, D; Song, C; Tan, J; Xu, C; Yuan, Y | 1 |
| Wen, S; Xu, X; Yadav, AK; Yu, L | 1 |
| Aghavali, S; Babadi, M; Daraie, P; Emamikhah, M; Jalili, M; Mehrabani, M; Mohaghegh, F; Pouranian, M; Rohani, M; Zaribafian, M | 1 |
| Aalipour, MA; Darazam, IA; Ghorbani, F; Pakdaman, H; Ramezani, M; Sagharichi, M; Simani, L | 1 |
| Baeza-Flores, GDC; Denis-García, CA; Flores-Barrientos, OI; Gonzalez-Castro, TB; Guzmán-Priego, CG; Juárez-Rojop, IE; López-Brito, CR; Narváez-Osorio, V; Nolasco-Rosales, GA; Pérez-García, A; Ruíz-Quiñonez, JA; Tovilla-Zarate, CA | 1 |
| Akbulut Koyuncu, İM; Kızıltunç, E; Uğurlu Ilgın, B | 1 |
| Dabbous, HM; Ebeid, FFS; El Assal, G; El-Sayed, MH; Elgaafary, M; Elghazaly, H; Fawzy, E; Hassany, SM; Riad, AR; Sherief, AF; TagelDin, MA | 1 |
| Isnaini, S; Ramatillah, DL | 1 |
| Anedda, L; Bianchini, L; Cuzzolin, L; Fanos, V; Finco, G; Marcialis, MA | 1 |
| Berk, H; Demir Önder, K; Öztoprak, N; Seremet Keskin, A; Seyman, D | 1 |
| Arabi, M; Bitar, F; Eid, AH; Fakhri, G; Younis, NK; Zareef, RO | 1 |
7 review(s) available for oseltamivir and hydroxychloroquine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Immunoglobulins; Immunologic Factors; Indoles; Lopinavir; Oseltamivir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Withholding Treatment | 2020 |
Current pharmacological treatments for SARS-COV-2: A narrative review.
Topics: Adenosine Monophosphate; Adjuvants, Immunologic; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Glucocorticoids; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Immunity, Innate; Inflammation Mediators; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome | 2020 |
Antiviral treatment in COVID-19: which is the most promising?-a narrative review.
Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Chloroquine; COVID-19; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Oseltamivir; Purines; Pyrazines; Pyrazoles; Ribavirin; Ritonavir; Sulfonamides; Thiazoles | 2021 |
Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
Topics: Adult; Anticonvulsants; Ataxia; Azithromycin; Clonazepam; Cough; COVID-19; COVID-19 Drug Treatment; Dyspnea; Female; Fever; Humans; Hydroxychloroquine; Levetiracetam; Male; Middle Aged; Myalgia; Opsoclonus-Myoclonus Syndrome; Oseltamivir; SARS-CoV-2; Valproic Acid | 2021 |
What if COVID-19 affects the child: which weapons and how to use them.
Topics: Adenosine Monophosphate; Adolescent; Age Factors; Alanine; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; Carrier State; Child; Child, Preschool; Chloroquine; Continuous Renal Replacement Therapy; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Extracorporeal Membrane Oxygenation; Glucocorticoids; Humans; Hydroxychloroquine; Immunization, Passive; Immunoglobulins, Intravenous; Immunologic Factors; Infant; Infant, Newborn; Interferon-alpha; Lopinavir; Oseltamivir; Receptors, Cell Surface; Respiration, Artificial; Ribavirin; Ritonavir; SARS-CoV-2; Severity of Illness Index; Thrombosis | 2021 |
COVID-19: potential therapeutics for pediatric patients.
Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Child; COVID-19 Drug Treatment; Dexamethasone; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Oseltamivir; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2021 |
3 trial(s) available for oseltamivir and hydroxychloroquine
| Article | Year |
|---|---|
Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A struc
Topics: Azithromycin; Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Oseltamivir; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Research Design; SARS-CoV-2 | 2020 |
RETRACTED: Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study.
Topics: Acetaminophen; Adult; Antiviral Agents; Betacoronavirus; Cephalosporins; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Repositioning; Egypt; Female; Humans; Hydrocortisone; Hydroxychloroquine; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Time Factors; Treatment Outcome | 2020 |
Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial.
Topics: Adult; Amides; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Humans; Hydroxychloroquine; Male; Middle Aged; Oseltamivir; Pyrazines; Treatment Outcome | 2021 |
22 other study(ies) available for oseltamivir and hydroxychloroquine
| Article | Year |
|---|---|
Advance of promising targets and agents against COVID-19 in China.
Topics: Adenine; Adenosine Monophosphate; Alanine; Amides; Antimalarials; Antiviral Agents; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Cobicistat; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Endopeptidases; Dibenzothiepins; Drug Combinations; Drug Discovery; Drug Therapy, Combination; Emtricitabine; Humans; Hydroxychloroquine; Indoles; Lopinavir; Medicine, Chinese Traditional; Morpholines; Oseltamivir; Oxazines; Pandemics; Pneumonia, Viral; Pyrazines; Pyridines; Pyridones; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tenofovir; Thiepins; Triazines; Viral Nonstructural Proteins | 2020 |
A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?
Topics: Aged; Antiviral Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Hydroxychloroquine; Oseltamivir; Pandemics; Pneumonia, Viral; Psoriasis | 2020 |
Case Report: Death due to COVID-19 in Three Brothers.
Topics: Aged; Betacoronavirus; Coronavirus Infections; COVID-19; Fatal Outcome; Genetic Predisposition to Disease; Humans; Hydroxychloroquine; Iran; Lung; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Siblings; Tomography, X-Ray Computed | 2020 |
"Reversed halo sign" on 3D CT in COVID-19.
Topics: Adult; Antimalarials; Antiviral Agents; Betacoronavirus; Body Fluids; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Humans; Hydroxychloroquine; Imaging, Three-Dimensional; Male; Nasopharynx; Oseltamivir; Pandemics; Pneumonia; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Dozens of coronavirus drugs are in development - what happens next?
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Coronavirus Infections; COVID-19; Drug Development; Drug Industry; Humans; Hydroxychloroquine; Oseltamivir; Pandemics; Pneumonia, Viral | 2020 |
Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab.
Topics: Aged; Antineoplastic Agents, Immunological; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Hydroxychloroquine; Lung Neoplasms; Melanoma; Multiple Chronic Conditions; Nivolumab; Oseltamivir; Pandemics; Pneumonia, Viral; Programmed Cell Death 1 Receptor; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Covid-19 and exacerbation of psoriasis.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Oseltamivir; Pandemics; Pneumonia, Viral; Psoriasis; SARS-CoV-2 | 2020 |
Characteristics of the initial patients hospitalized for COVID-19: a single-center report
Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Antihypertensive Agents; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; Female; Fever; Health Personnel; Humans; Hydroxychloroquine; Hypertension; Intensive Care Units; Lung; Male; Middle Aged; Myalgia; Oseltamivir; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Smoking; Tomography, X-Ray Computed; Travel; Turkey; Young Adult | 2020 |
The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study.
Topics: Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydroxychloroquine; Iran; Length of Stay; Levofloxacin; Lopinavir; Male; Meropenem; Middle Aged; Naproxen; Oseltamivir; Pneumonia, Viral; Prednisolone; Retrospective Studies; Ritonavir; Treatment Outcome; Vancomycin | 2020 |
Have the symptoms of patients with COVID-19 changed over time during hospitalization?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Coronavirus Infections; Cough; COVID-19; Diarrhea; Dyspnea; Female; Fever; Hospitalization; Humans; Hydroxychloroquine; Iran; Length of Stay; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Symptom Assessment; Young Adult | 2020 |
COVID-19 Pulmonary Infection with Pneumothorax in a Young Patient.
Topics: Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus; Coronavirus Infections; Cough; COVID-19; Enoxaparin; Female; Fever; Humans; Hydroxychloroquine; Lung; Male; Oseltamivir; Pandemics; Pneumonia, Viral; Pneumothorax; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2020 |
Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports.
Topics: Abdominal Pain; Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Chemical and Drug Induced Liver Injury; Chloroquine; COVID-19 Drug Treatment; Databases, Pharmaceutical; Diarrhea; Drug Combinations; Drug Eruptions; Drug Repositioning; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Male; Nausea; Oseltamivir; Ritonavir; Sex Distribution; Sex Factors; Vomiting | 2020 |
Acute aortic dissection in a patient with Williams syndrome infected by COVID-19.
Topics: Adolescent; Anti-Bacterial Agents; Antiviral Agents; Aortic Aneurysm; Aortic Dissection; Aortic Stenosis, Supravalvular; Aortitis; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Enzyme Inhibitors; Fatal Outcome; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Lopinavir; Male; Methylprednisolone; Oseltamivir; Recurrence; Ritonavir; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Williams Syndrome | 2021 |
Why we should be more careful using hydroxychloroquine in influenza season during COVID-19 pandemic?
Topics: Adult; Aged; Aged, 80 and over; Azithromycin; COVID-19 Drug Treatment; Electrocardiography; Female; Humans; Hydroxychloroquine; Influenza, Human; Long QT Syndrome; Male; Middle Aged; Oseltamivir; SARS-CoV-2 | 2021 |
Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.
Topics: Ampicillin; Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Child; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Drug Combinations; Enoxaparin; Humans; Hydroxychloroquine; Hypoxia; Immunoglobulins, Intravenous; Immunologic Factors; Lopinavir; Lung; Male; Mucocutaneous Lymph Node Syndrome; Oseltamivir; Oxygen Inhalation Therapy; Ritonavir; Sulbactam; Tomography, X-Ray Computed | 2021 |
Persistent hiccup: A rare presentation of COVID-19.
Topics: Baclofen; Biomarkers; COVID-19; COVID-19 Testing; Fever; Hiccup; Humans; Hydroxychloroquine; Male; Middle Aged; Oseltamivir; Pharyngitis; Rare Diseases; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2021 |
A retrospective comparison of drugs against COVID-19.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antibodies, Viral; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Female; Humans; Hydroxychloroquine; Immunoglobulin G; Immunoglobulin M; Indoles; Length of Stay; Lopinavir; Male; Middle Aged; Oseltamivir; Retrospective Studies; Ritonavir; SARS-CoV-2; Young Adult | 2021 |
Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
Topics: Adult; Aged; Antiviral Agents; Cough; COVID-19; COVID-19 Drug Treatment; Dementia; Drug Combinations; Dyspnea; Fatigue Syndrome, Chronic; Female; Fever; Humans; Hydroxychloroquine; Lopinavir; Male; Middle Aged; Oseltamivir; Research Design; Ritonavir; SARS-CoV-2; Severity of Illness Index; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Survivors | 2021 |
Features of patients that died for COVID-19 in a hospital in the south of Mexico: A observational cohort study.
Topics: Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Diabetes Mellitus, Type 1; Female; Hospital Mortality; Hospitals; Humans; Hydroxychloroquine; Length of Stay; Male; Mexico; Middle Aged; Obesity; Oseltamivir; Retrospective Studies; SARS-CoV-2; Sex Factors | 2021 |
Effect of triple antimicrobial therapy on electrocardiography parameters in patients with mild-to-moderate coronavirus disease 2019.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hydroxychloroquine; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Oseltamivir; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Young Adult | 2021 |
Treatment profiles and clinical outcomes of COVID-19 patients at private hospital in Jakarta.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Cohort Studies; Comorbidity; COVID-19; Female; Hospitals, Private; Humans; Hydroxychloroquine; Indonesia; Kaplan-Meier Estimate; Male; Middle Aged; Oseltamivir; Pandemics; Prospective Studies; SARS-CoV-2; Treatment Outcome | 2021 |
Retrospective evaluation of seven different treatment protocols in hospitalized COVID-19 patients
Topics: Adenosine Monophosphate; Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Amides; Antiviral Agents; Clinical Protocols; COVID-19; COVID-19 Nucleic Acid Testing; Female; Humans; Hydroxychloroquine; Length of Stay; Male; Middle Aged; Oseltamivir; Pandemics; Pyrazines; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Treatment Outcome; Young Adult | 2021 |